Are Your Degraders Delivering?

Uncover Mechanisms with CETSA®  This application note explores how CETSA reveals target specificity and mechanisms of action, helping optimize degrader molecules for clinical success. Learn from case studies on IMiDs, novel E3 ligase identification, and PROTAC profiling, showcasing CETSA’s ability to identify primary and off-target effects. Discover how CETSA supports degrader development through precise target engagement insights and functional outcome analysis.  Download now to see how CETSA can accelerate your protein degrader research and improve clinical outcomes.